(Q61453334)
Statements
Safety of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable stage III NSCLC after primary chemoradiotherapy: preliminary results from a Phase I/II study (English)
Fumiyoshi Ohyanagi
Takeshi Horai
Ikuo Sekine
Nobuyuki Yamamoto
Kazuhiko Nakagawa
Makoto Nishio
Nassim Morsli